Exploring New Horizons in Ophthalmology Care with Gene Therapy
JUN 27
Play
Description Community
About
If you’ve been keeping an eye on recent developments in ophthalmic care, then you’ll know that several new therapeutic agents that had been approved by the US Food and Drug Administration (FDA) in recent months, including ranibizumab delivered via Port Delivery System (PDS) and faricimab, the latter of which became the first-of-its-kind intravitreal bispecific biologic therapy for both age-related macular degeneration (AMD) and diabetic macular edema.

 

But the recent advancements in ophthalmology don’t stop there. As Veeral Sheth, MD, Director of Clinical Trials at University Retina would explain, there is so much going on in the world of eye care that it’s been “hard to keep track of all the work”.



In this episode of DocTalk, Dr. Sheth sits down with Associate Editor Connor Iapoce to discuss the potential of gene therapy, developments in the wet- and dry-AMD spaces, new approaches in the management of pigment dispersion syndrome, and the benefits of home-based optical coherence tomography.
Comments